(Q44279293)

1 December 2017

title

Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern (English)

1 reference

1 December 2017

1

Gianvincenzo Barba

0 references

author name string

Gianvincenzo Barba

1

1 reference

1 December 2017

Ornella Russo

2

1 reference

1 December 2017

Alfonso Siani

3

1 reference

1 December 2017

Roberto Iacone

4

1 reference

1 December 2017

Eduardo Farinaro

5

1 reference

1 December 2017

Maria Clara Gerardi

6

1 reference

1 December 2017

Paola Russo

7

1 reference

1 December 2017

Elisabetta Della Valle

8

1 reference

1 December 2017

Pasquale Strazzullo

9

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

11

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

160-166

1 reference

Weight and blood pressure. Findings in hypertension screening of 1 million Americans

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Obesity hypertension: role of leptin and sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Sympathetic and cardiorenal actions of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Chronic leptin infusion increases arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Pathophysiological role of leptin in obesity-related hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Independent association between plasma leptin levels and heart rate in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Uric acid metabolism and tubular sodium handling. Results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

High plasma leptin concentrations in hypertensive men but not in hypertensive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: A dissociation contributing to low blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Gender-dependent differences in plasma leptin in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Weight gain-induced blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Serum leptin levels and blood pressure in the overweight elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin and norepinephrine plasma concentrations during glucose loading in normotensive and hypertensive obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Cardiovascular consequences of obesity: role of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Interaction between leptin and sympathetic nervous system in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Is there a role for the ob gene product leptin in essential hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Sympathetic activity and body mass index contribute to blood pressure levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Differences in mechanisms between weight loss-sensitive and -resistant blood pressure reduction in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Receptor-mediated regional sympathetic nerve activation by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Body fat distribution, insulin resistance, and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin and other components of the Metabolic Syndrome in Mauritius—a factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

The relation of adiposity to blood pressure and development of hypertension. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Obesity in the new millennium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Treatment with CL 316,243, a beta 3-adrenoceptor agonist, reduces serum leptin in rats with diet- or aging-associated obesity, but not in Zucker rats with genetic (fa/fa) obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.25

31 March 2020

Identifiers

DOI

10.1038/OBY.2003.25

1 reference

1 December 2017

1 reference